Baldinu P, Cossu A, Manca A, Satta MP, Sini MC, Rozzo C, et al. Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. Hum Mutat. 2004;23(4):318–26. https://doi.org/10.1002/humu.20015.

Article  CAS  PubMed  Google Scholar 

Biswas S, Rao CM. Epigenetics in cancer: fundamentals and beyond. Pharmacol Ther. 2017;173:118–34. https://doi.org/10.1016/j.pharmthera.2017.02.011.

Article  CAS  PubMed  Google Scholar 

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Cai J, Zuo X, Chen Z, Zhao W, Zhu Y, Zhang Z, et al. Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis. Cancer Manag Res. 2018. https://doi.org/10.2147/CMAR.S161373.

Article  PubMed  PubMed Central  Google Scholar 

Cancer Genome Atlas Research Network. Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543(7645):378. https://doi.org/10.1038/nature21386.

Article  CAS  Google Scholar 

Dai W, Mu L, Cui Y, Li Y, Chen P, Xie H, et al. Berberine promotes apoptosis of colorectal cancer via regulation of the long non-coding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2)/AU-binding factor 1 (AUF1)/B-cell CLL/lymphoma 2 (Bcl-2) axis. Med Sci Monit. 2019;25:730. https://doi.org/10.12659/MSM.912082.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ding L, Tian Y, Wang L, Bi M, Teng D, Hong S. Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer. Aging (Albany NY). 2019;11(19):8139. https://doi.org/10.18632/aging.102309.

Article  CAS  PubMed  Google Scholar 

Erkinüresin T, Kartal E, Üstünyurt E, Demirci H, Kilitçi A, Önal B. Prevalence of high-risk human papillomavirus types and their association with cervical squamous cell carcinoma, and high-and low-grade squamous intraepithelial lesions in Turkish women. Iran J Public Health. 2023;52(3):612. https://doi.org/10.18502/ijph.v52i3.12144.

Article  PubMed  PubMed Central  Google Scholar 

Feng Y, Zou W, Hu C, Li G, Zhou S, He Y, et al. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin. Arch Biochem Biophys. 2017;623:20–30. https://doi.org/10.1016/j.abb.2017.05.001.

Article  CAS  PubMed  Google Scholar 

Gao W, Lin S, Cheng C, Zhu A, Hu Y, Shi Z, et al. Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel. Arch Biochem Biophys. 2019;665:69–78. https://doi.org/10.1016/j.abb.2018.01.013.

Article  CAS  PubMed  Google Scholar 

Ghafouri-Fard S, Dashti S, Taheri M. The role of long non-coding RNA CASC2 in the carcinogenesis process. Biomed Pharmacother. 2020;127: 110202. https://doi.org/10.1016/j.biopha.2020.110202.

Article  CAS  PubMed  Google Scholar 

He X, Liu Z, Su J, Yang J, Yin D, Han L, et al. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer. Tumour Biol. 2016;37:9503–10. https://doi.org/10.1007/s13277-016-4787-6.

Article  CAS  PubMed  Google Scholar 

Hoang PH, Landi MT. DNA methylation in lung cancer: mechanisms and associations with histological subtypes, molecular alterations, and major epidemiological factors. Cancers. 2022;14(4):961. https://doi.org/10.3390/cancers14040961.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang G, Wu X, Li S, Xu X, Zhu H, Chen X. The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer. Sci Rep. 2016;6(1):26524. https://doi.org/10.1038/srep26524.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kang J, Tang Q, He J, Li L, Yang N, Yu S, et al. RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility. Nucleic Acids Res. 2022;50(D1):D326–32. https://doi.org/10.1093/nar/gkab997.

Article  CAS  PubMed  Google Scholar 

Kashyap N, Krishnan N, Kaur S, Ghai S. Risk factors of cervical cancer: a case-control study. Asia Pac J Oncol Nurs. 2019;6(3):308–14. https://doi.org/10.4103/apjon.apjon_73_18.

Article  PubMed  PubMed Central  Google Scholar 

Kessler TA. Cervical cancer: prevention and early detection. In: Seminars in oncology nursing 2017 May 1 (Vol. 33, No. 2, pp. 172–183). WB Saunders. https://doi.org/10.1016/j.soncn.2017.02.005

Kusakabe M, Taguchi A, Sone K, Mori M, Osuga Y. Carcinogenesis and management of human papillomavirus-associated cervical cancer. Int J Clin Oncol. 2023;28(8):965–74. https://doi.org/10.1007/s10147-023-02337-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li QY, Yang K, Liu FG, Sun XG, Chen L, Xiu H, et al. Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1/2 and Wnt/β-catenin signaling pathway. Clin Transl Oncol. 2020;22:302–10. https://doi.org/10.1007/s12094-019-02223-7.

Article  CAS  PubMed  Google Scholar 

Li Y, Lv S, Ning H, Li K, Zhou X, Xv H, et al. Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a. Biomed Pharmacother. 2018;108:1775–82. https://doi.org/10.1016/j.biopha.2018.09.181.

Article  CAS  PubMed  Google Scholar 

Liu C, Tang H, Hu N, Li T. Methylomics and cancer: the current state of methylation profiling and marker development for clinical care. Cancer Cell Int. 2023;23(1):242. https://doi.org/10.1186/s12935-023-03074-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Locklar LR, Do DP. Rural-urban differences in HPV testing for cervical cancer screening. J Rural Health. 2022;38(2):409–15. https://doi.org/10.1111/jrh.12615.

Article  PubMed  Google Scholar 

Luo Q, Zeng X, Luo H, Pan L, Huang Y, Zhang H, et al. Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions. BMC Infect Dis. 2023;23(1):667. https://doi.org/10.1186/s12879-023-08634-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Manzo-Merino J, Contreras-Paredes A, Vázquez-Ulloa E, Rocha-Zavaleta L, Fuentes-Gonzalez AM, Lizano M. The role of signaling pathways in cervical cancer and molecular therapeutic targets. Arch Med Res. 2014;45(7):525–39. https://doi.org/10.1016/j.arcmed.2014.10.008.

Article  CAS  PubMed  Google Scholar 

Mekonnen AG, Mittiku YM. Early-onset of sexual activity as a potential risk of cervical cancer in Africa: a review of literature. PLOS Glob Public Health. 2023;3(3): e0000941. https://doi.org/10.1371/journal.pgph.0000941.

Article  PubMed  PubMed Central  Google Scholar 

Mlynarczyk-Bonikowska B, Rudnicka L. HPV infections—classification, pathogenesis, and potential new therapies. Int J Mol Sci. 2024;25(14):7616. https://doi.org/10.3390/ijms25147616.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Na J, Li Y, Wang J, Wang X, Lu J, Han S. The correlation between multiple HPV infections and the occurrence, development, and prognosis of cervical cancer. Front Microbiol. 2023;14:1220522. https://doi.org/10.3389/fmicb.2023.1220522.

Article  PubMed  PubMed Central  Google Scholar 

Palmieri G, Paliogiannis P, Sini MC, Manca A, Palomba G, Doneddu V, et al. Long non-coding RNA CASC2 in human cancer. Crit Rev Oncol Hematol. 2017;111:31–8. https://doi.org/10.1016/j.critrevonc.2017.01.003.